Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury.

Wu, Yuntao

Wu, Yuntao.

Wu Y; National Center for Biodefense and Infectious Diseases, School of Systems Biology, George Mason University, Manassas, VA, 20110, USA. ywu8@gmu.edu.

Virol Sin ; 35(3): 256-258, 2020 06.

Article in English | MEDLINE | ID: covidwho-485

Subject(s)

Acute Lung Injury/metabolism; Betacoronavirus/drug effects; Peptidyl-Dipeptidase A/metabolism; Peptidyl-Dipeptidase A/pharmacology; Acute Lung Injury/chemically induced; Acute Lung Injury/virology; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Coronavirus Infections/drug therapy; Coronavirus Infections/metabolism; Coronavirus Infections/virology; Disease Models, Animal; Host-Pathogen Interactions; Humans; Lung/drug effects; Lung/metabolism; Mice; Pandemics; Pneumonia, Viral/drug therapy; Pneumonia, Viral/metabolism; Pneumonia, Viral/virology; Receptor, Angiotensin, Type 1/metabolism; Receptor, Angiotensin, Type 2/metabolism; Receptors, Angiotensin/metabolism; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptidyl-Dipeptidase A / Acute Lung Injury / Betacoronavirus Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Virol Sin Journal subject: Virology Year: 2020 Document Type: Article Affiliation country: S12250-020-00205-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google